Related Experiment Video
Updated: Jun 27, 2026
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)
Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
Published on: January 24, 2025
Quantitative Assessment of Brain Glucose Metabolism Using Dynamic Glucose-Enhanced Magnetic Resonance Fingerprinting
Mou Jiang1, Yaping Yuan1,2, Yue Zhu1
1State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430071, P. R. China.
Abstract:
The brain relies heavily on glucose to sustain neuronal and glial functions, with metabolism closely regulated by both glucose levels and underlying physiological or pathological states. To investigate this complex process, a dynamic glucose-enhanced magnetic resonance fingerprinting (DGE-MRF) approach was implemented at a 9.4 T MRI system, integrating established multiparametric MRF with DGE-MRI and γ-variate kinetic modeling to track glucose uptake and clearance in gliomas. Dynamic ΔR 1, ΔR 2, and ΔR 1ρ curves revealed distinct temporal profiles: ΔR 1 peaked early, reflecting vascular glucose accumulation, whereas ΔR 2 and ΔR 1ρ captured slower tissue-level processes. Kinetic modeling using a γ-variate function demonstrated elevated glucose uptake rates (μin) and greater peak glucose changes (ΔG max) in gliomas, while clearance rates (μout) were comparable to those of controls. Overall, DGE-MRF provides accurate, reproducible, and region-specific mapping of cerebral glucose kinetics, offering a noninvasive framework for probing metabolic heterogeneity in gliomas and potential applications in tumor characterization and neurodegenerative disease research.

